BTIG Thinks Agilent's Transformation Is In The Early Innings

BTIG maintains its Buy rating on
Agilent Technologies IncA
) saying that the company's transformation is in its early stages and any weakness in shares on "conservative" fourth-quarter guidance offers a buying opportunity.

Agilent reported third-quarter adjusted EPS of $0.49, which was $0.02 above consensus estimate of $0.47 and above the high end of guidance of $0.45–$0.47. Revenue of $1.044 billion was essentially in line with consensus' $1.05 billion and within the guidance range of $1.03 billion–$1.05 billion.

Despite this outperformance, the company left its F16 core revenue growth and adjusted operating margin guidance unchanged, citing increased level of uncertainty among EU customers. This implies only +1.2 percent core revenue growth (versus consensus' +3.5 percent) and about 50 bp decline in operating margin in the fourth quarter after six consecutive quarters of operating margin expansion.

Related Link: Goldman Keeps Agilent On Conviction Buy List Following Mixed Q3, Light Guidance

Agilent expects fourth-quarter 2016 revenue in the range of $1.05 billion to $1.07 billion. Fourth-quarter non-GAAP earnings are expected to be in the range of $0.50 to $0.52 per share. The company's estimates fell short of Street mean of $0.54 EPS on revenue of $1.09 billion.

For fiscal year 2016, Agilent expects revenue of $4.14 billion to $4.16 billion and non-GAAP earnings of $1.89 to $1.91 per share. Analysts expect EPS of $1.91 on revenue of $4.18 billion.

"All told, while we understand mgmt's conservative strategy to setting guidance given recent macro concerns, we remain confident in our projections of 5 percent core revenue growth for F16 and continue to model F16 operating margins above the midpoint of guidance," analyst Karen Koski wrote in a note.

The analyst's F16 projection remains steady at $1.92, which is $0.01 above the top end of guidance of $1.89–$1.91. Koski has a price target of $55.

Shares of Agilent closed Wednesday's regular trading at $46.30. At time of writing Thursday, Agilent was down 4.25 percent at $46.38.

Full ratings data available on Benzinga Pro.

Do you have ideas for articles/interviews you'd like to see more of on Benzinga? Please email feedback@benzinga.com with your best article ideas. One person will be randomly selected to win a $20 Amazon gift card!
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: Analyst ColorBiotechEarningsLong IdeasNewsGuidancePrice TargetReiterationAnalyst RatingsMoversTrading IdeasGeneralbtigKaren Koski
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...